Amalgamated Financial’s Sana Biotechnology SANA Stock Holding History

Amalgamated Financial’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$114K	Buy	+13,859	New	+$112K	﹤0.01%	2095

Other funds holding SANA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Amalgamated Financial's SANA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Sana Biotechnology (SANA) in Q1 2022: 13,859 shares worth $114K. The stake represents ﹤0.01% of the portfolio and ranks #2095 among its holdings.

117 funds tracked by Wall St. Rank hold SANA as of Q1 2022.

Amalgamated Financial held 13,859 shares of Sana Biotechnology worth $114K as of Q1 2022.
Sana Biotechnology was a new Amalgamated Financial position in Q1 2022.
Sana Biotechnology made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2095 holding.
117 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.